# Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

Study · id `cardio:ct-nct02940860` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02940860](<https://clinicaltrials.gov/study/NCT02940860>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02940860

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1538 participants.

## Technical summary

Registry record NCT02940860. Randomized; no masking; primary purpose treatment. Start 2016-11-29 (actual); primary completion 2018-05-29 (actual). Results posted on 2020-03-06.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1538 participants (enrolled count; ClinicalTrials.gov record NCT02940860, source copy `cardio:ctgov-nct02940860-2020-10-06`, retrieved 2026-10-26)
- Started: 2016-11-29 (actual) (ClinicalTrials.gov record NCT02940860, source copy `cardio:ctgov-nct02940860-2020-10-06`, retrieved 2026-10-26)
- Primary completion: 2018-05-29 (actual) (ClinicalTrials.gov record NCT02940860, source copy `cardio:ctgov-nct02940860-2020-10-06`, retrieved 2026-10-26)
- Completion: 2018-05-29 (actual) (ClinicalTrials.gov record NCT02940860, source copy `cardio:ctgov-nct02940860-2020-10-06`, retrieved 2026-10-26)
- Results first posted: 2020-03-06 (ClinicalTrials.gov record NCT02940860, source copy `cardio:ctgov-nct02940860-2020-10-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02940860, source copy `cardio:ctgov-nct02940860-2020-10-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02940860-2020-10-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
- Condition: Iron Deficiency Anaemia
- Condition: Iron Deficiency Anemia
- Condition: Chronic Kidney Disease
- Intervention (Drug): Iron isomaltoside/ferric derisomaltose
- Intervention (Drug): Iron sucrose
- Lead sponsor: Pharmacosmos A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Pharmacosmos A/S (`cardio:org-pharmacosmos-a-s`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial (`cardio:pubmed-32049331`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4564330995af117e08d83e91c796bcdcf023a763a2736e8f05462c4107403cd3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
